Back to search

Ireland· IE-PA-PA0749/064/001

Risonate Once Weekly 35 mg Film-coated Tablets

A risedronic acid product containing risedronate sodium, registered in Ireland by Teva Pharma B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC M05BA07

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedRisonate Once Weekly 35 mg Film-coate…ATCM05BA07REGISTER NO.IE-PA-PA0749/064/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Risedronic acid is registered in 14 of 19 countries.

Countries holding a registration under ATC M05BA07 (risedronic acid), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Risedronic acid · ATC M05BA07

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of risedronic acid costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.45 in Italy to $1.17 in Switzerland — a ×2.6 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Risedronic acid · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.17
  • IT Italy$0.45
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Risedronate sodium
Manufacturer
Teva Pharma B.V.
Country
Ireland (IE)
ATC code
M05BA07
ATC class
Risedronic acid
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0749/064/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

293 interactions on record for risedronic acid.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Risedronic acid · interactions on record

293 records

  • 2 severe
  • 68 moderate
  • 204 info

Most severe, free to view

  • EtelcalcetideH05BX04severe
  • DeferasiroxV03AC03severe
  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate

19 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Risedronic acid in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All risedronic acid products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Actonel Einmal Wöchentlich, Risedronat Einmal Wöchentlich Stada
  • Belgium · Actonel, Actonel Hebdomadaire
  • Bulgaria · Зилар, Ризида
  • Cyprus · Actonel «2 Συνεχόμενεσ Ημέρεσ Το Μήνα», Actonel Oaw/«μία Φορά Την Εβδομάδα»
  • Czechia · Risedronat Teva, Risendros
  • Germany · Acara, Actonel
  • Denmark · Karadronat, Optinate Septimum
  • Estonia · Norifaz
  • Spain · Acrel Semanal, Actonel
  • Finland · Optinate Septimum, Risedronat Sandoz
  • France · Actonel, Risedronat Viatris
  • United Kingdom (Northern Ireland) · Actonel Once A Week, Risedronate Sodium Accord-Uk
  • Greece · Actonel, Actonel Gr
  • Croatia · Actonel, Bonna
  • Hungary · Actonel, Boneact
  • Iceland · Risedronate Bluefish
  • Italy · Actonel, Optinate
  • Lithuania · Norifaz, Risendros
  • Luxembourg · Actonel, Actonel Hebdomadaire
  • Latvia · Norifaz, Risendros
  • Malta · Risedronate Aurobindo, Risedronate Once A Week Aurobindo
  • Netherlands · Actonel, Actonel Wekelijks
  • Poland · Norifaz, Risendros 35
  • Portugal · Actonel, Risedronato De Sódio Alter
  • Romania · Actonel, Risedronat Arena
  • Sweden · Avestra, Avestra Septimum
  • Slovenia · Actonel
  • Slovakia · Risendros

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7b55a85-69d0-45c5-9ebe-d27405ba2062
GET /v1/drugs/c7b55a85-69d0-45c5-9ebe-d27405ba2062?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "M05BA",
    "M05BA07"
  ],
  "strength": null,
  "pa_number": "PA0749/064/001",
  "substances": [
    "Risedronate sodium"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "12/12/2008",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0068-124-003"
}

See everything about risedronic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.